StoneX Group Portfolio holdings
StoneX Group is a financial services firm that has six lines of business: foreign exchange, securities, physical commodities, global payments, commercial hedging, and clearing and execution services. It was known as INTL FCStone until 2020, a name chosen in 2011 after International Assets Holding Corporation merged with FCStone Group. In 2019 it launched a prime brokerage division that clears trades for hedge funds, mutual funds and family offices. In 2020 StoneX agreed to buy GAIN Capital, the operator of the Forex.com and City Index retail trading brands.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Semiconductor ETF
SOXX
|
+$27.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$21.3M |
| 3 |
iShares MSCI ACWI ETF
ACWI
|
+$14.4M |
| 4 |
Micron Technology
MU
|
+$14.2M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$8.54M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KT
KT
|
+$25.8M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$16.1M |
| 3 |
Xcel Energy
XEL
|
+$13.3M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$11.2M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$9.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.27% |
| 2 | Technology | 9.13% |
| 3 | Financials | 7.69% |
| 4 | Industrials | 2.87% |
| 5 | Healthcare | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
Golden Sun Technology Group
GSUN
$1.81M
| $9.6K | ﹤0.01% |
+40,450
| New | +$12.8K |
2026 Q3
0 quarters
|
|
1852
Rain Enhancement Technologies
RAIN
$6.84M
| $9.46K | ﹤0.01% |
+11,763
| New | +$14K |
2026 Q3
0 quarters
|
|
1853
Mangoceuticals
MGRX
$4.6M
| $9.4K | ﹤0.01% |
+24,099
| New | +$10.7K |
2026 Q3
0 quarters
|
|
1854
Ridgetech Inc
RDGT
$2.83M
| $9.35K | ﹤0.01% |
+10,450
| New | +$10.8K |
2026 Q3
0 quarters
|
|
|
EDVA
1855
Endovia Health Sciences, Inc.
EDVA
$2.11M
| $8.94K | ﹤0.01% |
27,407
+20,369
| +289% | +$7.42K |
2026 Q2
1 quarter
|
|
1856
Rein Therapeutics
RNTX
$56.8M
| $8.84K | ﹤0.01% |
+11,783
| New | +$9.7K |
2026 Q3
0 quarters
|
|
1857
Fractyl Health
GUTS
$12.9M
| $8.66K | ﹤0.01% |
1,053
+186
| +21% | +$1.54K |
2026 Q2
1 quarter
|
|
|
SDST
1858
DELISTED
STARDUST POWER INC
SDST
| $8.58K | ﹤0.01% |
+23,199
| New | +$17.9K |
2026 Q3
0 quarters
|
|
1859
Biodexa Pharmaceuticals
BDRX
$741K
| $8.37K | ﹤0.01% |
+1,562
| New | +$17.8K |
2026 Q3
0 quarters
|
|
|
HODO
1860
DELISTED
House of Doge
HODO
| $8.35K | ﹤0.01% |
+43,470
| New | +$28.9K |
2026 Q3
0 quarters
|
|
|
XTERW
1861
Karman Line Acquisition Corp. Warrants
XTERW
| $8.2K | ﹤0.01% |
+32,816
| New | +$8.76K |
2026 Q3
0 quarters
|
|
1862
Maywood Acquisition Corp 2 Warrants
MYXXW
| $8.03K | ﹤0.01% |
112,300
+74,800
| +199% | +$5.72K |
2026 Q2
1 quarter
|
|
1863
Blaize Holdings Warrants
BZAIW
$667K
| $7.94K | ﹤0.01% |
62,045
+16,215
| +35% | +$2.94K |
2026 Q2
1 quarter
|
|
1864
cbdMD
YCBD
$4.55M
| $7.89K | ﹤0.01% |
16,335
+3,603
| +28% | +$1.96K |
2026 Q2
1 quarter
|
|
1865
Generation Income Properties
GIPR
$886K
| $7.69K | ﹤0.01% |
+19,580
| New | +$14.2K |
2026 Q3
0 quarters
|
|
1866
Kandal M Venture Ltd
FMFC
$1.8M
| $7.61K | ﹤0.01% |
913
+202
| +28% | +$1.94K |
2026 Q2
1 quarter
|
|
1867
SIM Acquisition Corp I Warrant
SIMAW
| $7.41K | ﹤0.01% |
41,123
-10,411
| -20% | -$2.07K |
2026 Q2
1 quarter
|
|
1868
Theriva Biologics
TOVX
$8.72M
| $7.35K | ﹤0.01% |
+32,106
| New | +$7.49K |
2026 Q3
0 quarters
|
|
1869
Crown Reserve Acquisition Corp I Warrant
CRACW
$172K
| $7.32K | ﹤0.01% |
194,094
-1,500
| -0.8% | -$73 |
2025 Q4
3 quarters
|
|
1870
Destination XL Group
DXLG
$27.1M
| $7.31K | ﹤0.01% |
+16,543
| New | +$10K |
2026 Q3
0 quarters
|
|
1871
SkinHealth Systems
SKIN
$72M
| $7.15K | ﹤0.01% |
529
-312
| -37% | -$4.48K |
2026 Q2
1 quarter
|
|
1872
DELISTED
Leslie's
LESL
| $6.85K | ﹤0.01% |
+10,414
| New | +$18.3K |
2026 Q3
0 quarters
|
|
1873
Australian Oilseeds Holdings
COOT
$14M
| $6.6K | ﹤0.01% |
+14,976
| New | +$6.8K |
2026 Q3
0 quarters
|
|
1874
Murano Global Investments
MRNO
$17.3M
| $6.36K | ﹤0.01% |
20,042
-3
| -0% | -$1 |
2026 Q2
1 quarter
|
|
1875
Mustang Bio
MBIO
$3.14M
| $6.14K | ﹤0.01% |
+11,604
| New | +$6.73K |
2026 Q3
0 quarters
|
|
Similar funds
StoneX Group's Q3 2026 Portfolio in Review
As of Q3 2026, StoneX Group held 2,403 positions worth $2.75B, up 11% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
StoneX Group deployed $299M of net new capital in Q3 2026, opening 939 new positions and adding to 616 existing holdings. Its largest new stake was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 70% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $16.1M trimmed.
- StoneX Group's largest Q3 2026 buy was iShares MSCI ACWI ETF: 90,830 shares worth $14.4M.
- StoneX Group added most to iShares Semiconductor ETF in Q3 2026, an estimated $27.9M increase.
- StoneX Group's biggest Q3 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $16.1M.
- StoneX Group fully exited KT in Q3 2026, selling an estimated $25.8M.
- StoneX Group's ten largest holdings make up 25% of its $2.75B portfolio in Q3 2026.
- StoneX Group opened 939 new positions and closed 465 in Q3 2026.
- StoneX Group's portfolio value rose 11% quarter-over-quarter to $2.75B.
Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.